FDLI: Annual Meeting

Exhibiting: Booth # TBA

ProPharma is pleased to confirm its participation as an exhibitor at the FDLI 2026 Annual Conference, taking place May 6–7, 2026 in Washington, DC. This premier event brings together food and drug law professionals, regulatory experts, industry leaders, policy makers, and legal practitioners to explore the most pressing legal, regulatory, compliance, and policy issues currently impacting FDA-regulated industries. Attendees will have the opportunity to engage in over 30 sessions, gain insights from more than 100 leading experts, and hear strategic priorities directly from FDA leadership and other key stakeholders.

ProPharma representatives look forward to attending, connecting with peers, sharing expertise, and engaging with the dynamic regulatory community at this influential industry gathering

Attendees:

• Marshall Florence
• Bobbi Druyor-Sanchez

Speaking Opportunities

• Do You Copy? Biosimilars, Generics, Fast Tracks and Fine Prints
  Wednesday, May 6 | 3:10–4:10 PM
  Marshall Florence, Vice President, Labeling and Strategy, ProPharma
• QMSR Goes Live! Inspection Insights, Audit Approaches, and QMS Queries
  Thursday, May 7 | 11:15 AM–12:15 PM
  Bobbi Druyor-Sanchez, Partner, ProPharma